NOVA will broadcast a program about the Dover intelligent design court case.
This week's Nature has Drosophila, high resolution protein structure modeling, the NIH, and more.
VentureBeat's David Hamilton takes a closer look at Navigenics' product.
The dandruff-causing fungus's genome is sequenced.
A new idea for paper authorship is to be like a movie's credit roll.
Derek Lowe discusses the link between pharma and the movie business.
A blogger lists why not to be a scientist.
PubMed adds drug information to its articles.
Jonathan Eisen supports open access.
A series of papers in PLoS Biology discuss how sex ratio is influenced by RNAi.
Direct-to-consumer genetic tests will be launched next year.
MIT's Technology Review interviews the Whitehead Institute's Robert Weinberg.
Population genomics research looks at a relative of D. melanogaster, Drosophila simulans.
Lung adenocarcinomas genomes contain copy number changes.
Blogger David Ng has a song about scientific jargon.
GMO plants will use RNAi to kill pests.
Baylor pairs next-gen sequencing with microarrays with for resequencing.
Blogger Deepak Singh wonders if scientists would ever be ready for labs powered by mobile devices rather than personal computers.
NIH studies why women leave scientific research.
Science covers glycobiology, Linnaeus, and the circadian clock in this week's issue.
Phil Green points out the flaws of continuing to assemble 2x sequences.
Open access is defined -- again.
George Church sells the $1,000 genome.
Members of the US House and Senate meet today to finalize the 2008 Department of Health and Human Services appropriations bill.
Keith Robison blogs about "Easter Eggs."
Pennsylvania State University's Kathleen Grogan says researchers need to approach data on gender and racial diversity in the sciences like they would any other dataset.
The National Science Foundation is adding questions about sexual orientation and gender identity to its Survey of Earned Doctorates, according to Science Careers.
Nature asked scientists whether they were satisfied with their careers to find that most were, with some variation.
Gene editing is expected to give rise to new job opportunities, according to BBC Capital.